Cargando…

Drug-resistant tuberculosis: Progress towards shorter and safer regimens

Detalles Bibliográficos
Autores principales:	Saravu, Kavitha, Pai, Madhukar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710955/ https://www.ncbi.nlm.nih.gov/pubmed/31464207 http://dx.doi.org/10.4103/lungindia.lungindia_350_19

Ejemplares similares

Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis
por: Weyer, Karin, et al.
Publicado: (2018)

Shorter TB treatment regimens should be safer as well
por: Rucsineanu, O., et al.
Publicado: (2023)

Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
por: Prasad, Rajendra, et al.
Publicado: (2017)

Antimicrobial resistance and the growing threat of drug-resistant tuberculosis
por: Pai, Madhukar, et al.
Publicado: (2016)

Cost Effectiveness of a Shorter Moxifloxacin Based Regimen for Treating Drug Sensitive Tuberculosis in India
por: Muniyandi, Malaisamy, et al.
Publicado: (2022)

Making the Case for All-Oral, Shorter Regimens for Children with Drug-Resistant Tuberculosis
por: Patankar, Sayalee, et al.
Publicado: (2023)

Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen
por: Lempens, Pauline, et al.
Publicado: (2020)

Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope
por: Prasad, Rajendra, et al.
Publicado: (2017)

Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes
por: Decroo, Tom, et al.
Publicado: (2020)

Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan
por: du Cros, Philipp, et al.
Publicado: (2021)

Tuberculosis therapy in Mumbai: Critical importance of drug-susceptibility testing
por: Daftary, Amrita, et al.
Publicado: (2016)

Towards better and safer blood transfusion
por: Cho, Duck
Publicado: (2013)

Prevalence of diabetes mellitus amongst hospitalized tuberculosis patients at an Indian tertiary care center: A descriptive analysis
por: Pande, Tripti, et al.
Publicado: (2018)

Towards safer use of pesticides in Chile
por: Coria, Jessica, et al.
Publicado: (2022)

Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens
por: Kusmiati, Tutik, et al.
Publicado: (2022)

Programme costs of longer and shorter tuberculosis drug regimens and drug import: a modelling study for Karakalpakstan, Uzbekistan
por: Kohler, Stefan, et al.
Publicado: (2022)

Limited Scope of Shorter Drug Regimen for MDR TB Caused by High Resistance to Fluoroquinolone
por: Singh, Pravin K., et al.
Publicado: (2019)

The Prescribing Skills Assessment: a step towards safer prescribing
por: Harrison, Claire, et al.
Publicado: (2019)

Time for high-burden countries to lead the tuberculosis research agenda
por: Pai, Madhukar
Publicado: (2018)

Testing and Treating the Missing Millions with Tuberculosis
por: Pai, Madhukar, et al.
Publicado: (2015)

Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis
por: Trubnikov, Aleksandr, et al.
Publicado: (2021)

Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019–2020
por: Avaliani, Teona, et al.
Publicado: (2021)

The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan
por: Kohler, Stefan, et al.
Publicado: (2022)

Improving the quality of tuberculosis care: We need standards and strategies to translate them into practice
por: Pai, Madhukar
Publicado: (2014)

Management of latent tuberculosis infection: An evidence-based approach
por: Pai, Madhukar, et al.
Publicado: (2015)

India is well placed to scale innovations in tuberculosis diagnostics
por: Pai, Madhukar, et al.
Publicado: (2023)

Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis
por: Fofana, Mariam O., et al.
Publicado: (2014)

Promoting Affordable and Quality Tuberculosis Testing in India
por: Pai, Madhukar
Publicado: (2013)

Tuberculosis diagnostics: Why we need more qualitative research
por: Engel, Nora, et al.
Publicado: (2013)

India’s syndemic of tuberculosis and COVID-19
por: Shrinivasan, Rukmini, et al.
Publicado: (2020)

Performance of the Xpert HIV-1 Viral Load Assay: a Systematic Review and Meta-analysis
por: Nash, Madlen, et al.
Publicado: (2018)

Global tuberculosis control requires greater ambition and resources
por: Pai, Madhukar, et al.
Publicado: (2015)

New tuberculosis estimates must motivate countries to act
por: Pai, Madhukar, et al.
Publicado: (2017)

India's fight against tuberculosis: How can chest physicians help?
por: Pai, Madhukar, et al.
Publicado: (2017)

Designing Safer Chemicals
por: Birnbaum, Linda S.
Publicado: (2013)

Enhancing the role of pharmacists in the cascade of tuberculosis care
por: Daftary, Amrita, et al.
Publicado: (2017)

Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country
por: Wahid, Abdul, et al.
Publicado: (2022)

Promise and Peril of Pretomanid–Rifamycin Regimens for Drug-susceptible Tuberculosis
por: Velásquez, Gustavo E., et al.
Publicado: (2023)

Innovations in Tuberculosis Diagnostics: Progress and Translational Challenges
por: Pai, Madhukar
Publicado: (2015)

Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO
por: Stringer, Beverley, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ssv0jt92tp3knn1o3e533d5ur9